Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
14.25
-0.19 (-1.32%)
Apr 8, 2026, 3:04 PM CST

SHE:002675 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
871.93757.01644.421,022826.61
Trading Asset Securities
225.22148.5420.1227.33129.27
Cash & Short-Term Investments
1,097905.55664.531,049955.88
Cash Growth
21.16%36.27%-36.65%9.74%14.64%
Accounts Receivable
989.89936.24794.08883.53875.48
Other Receivables
5.050.6510.9662.1319.06
Receivables
994.94936.89805.04945.66894.55
Inventory
532.57646.22903.861,078952.53
Other Current Assets
60.2878.99104.25120.0596.81
Total Current Assets
2,6852,5682,4783,1932,900
Property, Plant & Equipment
2,6292,3352,1471,9641,616
Long-Term Investments
383.91356.05212.92191.1243.37
Goodwill
2,4912,5012,5442,3302,373
Other Intangible Assets
281.68252.54219.44226.06191.41
Long-Term Deferred Tax Assets
134.6694.8988.0363.7158.61
Long-Term Deferred Charges
444.73363.02243133.24177.03
Other Long-Term Assets
173.43164.82150.3776.6996.54
Total Assets
9,2248,6358,0828,1777,656
Accounts Payable
583.93588.41876.021,3321,052
Accrued Expenses
337.36281.49240.55255.3216.99
Short-Term Debt
252490.23372.97391.47365.96
Current Portion of Long-Term Debt
68.4464.65147.646.66156.37
Current Portion of Leases
18.149.3411.394.993.69
Current Income Taxes Payable
57.4947.9653.4656.6136.14
Current Unearned Revenue
87.1106.01114.25108.8268.47
Other Current Liabilities
231.55165.87135.48197.72143.11
Total Current Liabilities
1,6361,7541,9522,3932,043
Long-Term Debt
297.33301.86249.21232.6520.36
Long-Term Leases
140.433.8811.077.532.89
Long-Term Unearned Revenue
192.28196.79236.97240.2747.33
Long-Term Deferred Tax Liabilities
22.6917.4118.118.6316.76
Other Long-Term Liabilities
1,471959.32219.662.222.22
Total Liabilities
3,7603,2632,6872,8952,633
Common Stock
824.6824.6824.6824.6802.21
Additional Paid-In Capital
1,7001,9982,3412,4022,317
Retained Earnings
1,8141,6431,6031,5171,290
Comprehensive Income & Other
11.8114.846.864.84-11.78
Total Common Equity
4,3504,4804,7754,7494,397
Minority Interest
1,114891.02620.22533.66626.35
Shareholders' Equity
5,4645,3715,3965,2825,024
Total Liabilities & Equity
9,2248,6358,0828,1777,656
Total Debt
776.32899.96792.23683.251,049
Net Cash (Debt)
320.835.59-127.7365.7-93.39
Net Cash Growth
5638.53%----
Net Cash Per Share
0.390.01-0.150.45-0.12
Filing Date Shares Outstanding
824.6824.6824.6824.6802.21
Total Common Shares Outstanding
824.6824.6824.6824.6802.21
Working Capital
1,049813.69525.96799.34856.82
Book Value Per Share
5.285.435.795.765.48
Tangible Book Value
1,5771,7272,0122,1931,833
Tangible Book Value Per Share
1.912.092.442.662.28
Buildings
1,6171,4901,1961,119869.32
Machinery
1,2911,162943.15870.18747.8
Construction In Progress
639.8567.91780.03641.37561.05
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.